BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17150192)

  • 1. Collagen expression in fibroblasts with a novel LMNA mutation.
    Nguyen D; Leistritz DF; Turner L; MacGregor D; Ohson K; Dancey P; Martin GM; Oshima J
    Biochem Biophys Res Commun; 2007 Jan; 352(3):603-8. PubMed ID: 17150192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Lamin A Mutant Responsible for Congenital Muscular Dystrophy Causes Distinct Abnormalities of the Cell Nucleus.
    Barateau A; Vadrot N; Vicart P; Ferreiro A; Mayer M; Héron D; Vigouroux C; Buendia B
    PLoS One; 2017; 12(1):e0169189. PubMed ID: 28125586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical progeroid syndrome due to heterozygous missense LMNA mutations.
    Garg A; Subramanyam L; Agarwal AK; Simha V; Levine B; D'Apice MR; Novelli G; Crow Y
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4971-83. PubMed ID: 19875478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe mandibuloacral dysplasia-associated lipodystrophy and progeria in a young girl with a novel homozygous Arg527Cys LMNA mutation.
    Agarwal AK; Kazachkova I; Ten S; Garg A
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4617-23. PubMed ID: 18796515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homozygous mutation in the lamin A/C gene associated with a novel syndrome of arthropathy, tendinous calcinosis, and progeroid features.
    Van Esch H; Agarwal AK; Debeer P; Fryns JP; Garg A
    J Clin Endocrinol Metab; 2006 Feb; 91(2):517-21. PubMed ID: 16278265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
    Decaudain A; Vantyghem MC; Guerci B; Hécart AC; Auclair M; Reznik Y; Narbonne H; Ducluzeau PH; Donadille B; Lebbé C; Béréziat V; Capeau J; Lascols O; Vigouroux C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4835-44. PubMed ID: 17711925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype.
    Lombardi F; Gullotta F; Columbaro M; Filareto A; D'Adamo M; Vielle A; Guglielmi V; Nardone AM; Azzolini V; Grosso E; Lattanzi G; D'Apice MR; Masala S; Maraldi NM; Sbraccia P; Novelli G
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4467-71. PubMed ID: 17848409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminopathies: multisystem dystrophy syndromes.
    Jacob KN; Garg A
    Mol Genet Metab; 2006 Apr; 87(4):289-302. PubMed ID: 16364671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations.
    Mory PB; Crispim F; Freire MB; Salles JE; Valério CM; Godoy-Matos AF; Dib SA; Moisés RS
    Eur J Endocrinol; 2012 Sep; 167(3):423-31. PubMed ID: 22700598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
    Hussain I; Patni N; Ueda M; Sorkina E; Valerio CM; Cochran E; Brown RJ; Peeden J; Tikhonovich Y; Tiulpakov A; Stender SRS; Klouda E; Tayeh MK; Innis JW; Meyer A; Lal P; Godoy-Matos AF; Teles MG; Adams-Huet B; Rader DJ; Hegele RA; Oral EA; Garg A
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1005-1014. PubMed ID: 29267953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A.
    Huang S; Risques RA; Martin GM; Rabinovitch PS; Oshima J
    Exp Cell Res; 2008 Jan; 314(1):82-91. PubMed ID: 17870066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progeroid laminopathy with restrictive dermopathy-like features caused by an isodisomic LMNA mutation p.R435C.
    Starke S; Meinke P; Camozzi D; Mattioli E; Pfaeffle R; Siekmeyer M; Hirsch W; Horn LC; Paasch U; Mitter D; Lattanzi G; Wehnert M; Kiess W
    Aging (Albany NY); 2013 Jun; 5(6):445-59. PubMed ID: 23804595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking at New Unexpected Disease Targets in
    Mosbah H; Vatier C; Boccara F; Jéru I; Lascols O; Vantyghem MC; Fève B; Donadille B; Sarrazin E; Benabbou S; Inamo J; Ederhy S; Cohen A; Neraud B; Richard P; Picard F; Christin-Maitre S; Redheuil A; Wahbi K; Vigouroux C
    Cells; 2020 Mar; 9(3):. PubMed ID: 32245113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives.
    Vigouroux C; Guénantin AC; Vatier C; Capel E; Le Dour C; Afonso P; Bidault G; Béréziat V; Lascols O; Capeau J; Briand N; Jéru I
    Nucleus; 2018 Jan; 9(1):235-248. PubMed ID: 29578370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subtype of laminopathies: Generalized lipodystrophy-associated progeroid syndrome caused by LMNA gene c.29C>T mutation.
    Huang S; Zhang Y; Zhan Z; Gong S
    J Diabetes Investig; 2023 Oct; 14(10):1221-1225. PubMed ID: 37448194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A.
    Le Dour C; Schneebeli S; Bakiri F; Darcel F; Jacquemont ML; Maubert MA; Auclair M; Jeziorowska D; Reznik Y; Béréziat V; Capeau J; Lascols O; Vigouroux C
    J Clin Endocrinol Metab; 2011 May; 96(5):E856-62. PubMed ID: 21346069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft substrates normalize nuclear morphology and prevent nuclear rupture in fibroblasts from a laminopathy patient with compound heterozygous LMNA mutations.
    Tamiello C; Kamps MA; van den Wijngaard A; Verstraeten VL; Baaijens FP; Broers JL; Bouten CC
    Nucleus; 2013; 4(1):61-73. PubMed ID: 23324461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
    Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
    BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation.
    Afonso P; Auclair M; Boccara F; Vantyghem MC; Katlama C; Capeau J; Vigouroux C; Caron-Debarle M
    Atherosclerosis; 2016 Feb; 245():200-11. PubMed ID: 26724531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of fibroblast nuclear morphology aids interpretation of LMNA variants.
    van Tienen FHJ; Lindsey PJ; Kamps MAF; Krapels IP; Ramaekers FCS; Brunner HG; van den Wijngaard A; Broers JLV
    Eur J Hum Genet; 2019 Mar; 27(3):389-399. PubMed ID: 30420677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.